CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq:CERU), today announced that four abstracts on its lead candidate, CRLX101, are included in the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago from May 29 through June 2.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
